These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28089143)

  • 1. Long-term mortality following Pseudomonas aeruginosa bloodstream infection.
    McCarthy KL; Paterson DL
    J Hosp Infect; 2017 Mar; 95(3):292-299. PubMed ID: 28089143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired Pseudomonas aeruginosa bloodstream infection: a classification that should not falsely reassure the clinician.
    McCarthy KL; Paterson DL
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):703-711. PubMed ID: 27942878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study.
    Pilmis B; Alby-Laurent F; Fasola ML; Seegers V; Guery R; Guet-Revillet H; Postaire M; Toubiana J; Bille E; Lortholary O; Zahar JR
    Eur J Pediatr; 2020 Aug; 179(8):1247-1254. PubMed ID: 32080759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
    Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
    Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
    McCarthy KL; Paterson DL
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):152-157. PubMed ID: 28366610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections.
    Marra AR; Bearman GM; Wenzel RP; Edmond MB
    BMC Infect Dis; 2005 Oct; 5():94. PubMed ID: 16259623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia.
    Tang PC; Lee CC; Li CW; Li MC; Ko WC; Lee NY
    J Microbiol Immunol Infect; 2017 Aug; 50(4):486-493. PubMed ID: 26455486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of bloodstream infection mortality risk score in a population-based cohort.
    Al-Hasan MN; Juhn YJ; Bang DW; Yang HJ; Baddour LM
    Clin Microbiol Infect; 2014 Sep; 20(9):886-91. PubMed ID: 25455590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.
    Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Fattah MA; Haquin J; MacGowan A; Grier S; Chazan B; Yanovskay A; Ami RB; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Maurer S; Rodriguez-Bano J; Morales I; Oliver A; de Gopegui ER; Cano A; Machuca I; Gozalo-Marguello M; Martinez-Martinez L; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
    Int J Antimicrob Agents; 2020 Feb; 55(2):105847. PubMed ID: 31770625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
    Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
    J Am Geriatr Soc; 2006 May; 54(5):804-8. PubMed ID: 16696747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tree-structured survival analysis of patients with Pseudomonas aeruginosa bacteremia: A multicenter observational cohort study.
    Yoon YK; Kim HA; Ryu SY; Lee EJ; Lee MS; Kim J; Park SY; Yang KS; Kim SW;
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):180-187. PubMed ID: 27863948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa.
    Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB
    J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.
    Zavascki AP; Barth AL; Fernandes JF; Moro AL; Gonçalves AL; Goldani LZ
    Crit Care; 2006; 10(4):R114. PubMed ID: 16882337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection.
    Willmann M; Kuebart I; Vogel W; Flesch I; Markert U; Marschal M; Schröppel K; Autenrieth IB; Hölzl F; Peter S
    J Infect; 2013 Nov; 67(5):416-23. PubMed ID: 23817209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.